ANDA 90099, held by Am Regent. Fosphenytoin Sodium.
As of Nov 16, 2026, ANDA 90099 (Fosphenytoin Sodium), held by Am Regent, was first approved by FDA on May 13, 2010, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 13, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fosphenytoin SodiumEQ 50MG PHENYTOIN NA/ML · injectable;injection | Fosphenytoin Sodium | Discontinued |
| Nov 14, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 10, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 13, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters